secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apogee Therapeutics, Inc. (APGE)
CIK:        0001974640
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001104659-26-034579
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apogee Therapeutics prices public offering of 5M shares at $70, net ~$377.4M
----------------------------------------------------------------------------

- 5,000,000 shares offered at $70 per share; underwriters' option for 750,000 shares exercised in full.
- Net proceeds expected ~$377.4M after underwriting discounts and commissions and estimated expenses.
- Offering expected to close March 26, 2026; underwriters include Jefferies, TD Securities, Stifel, Guggenheim.
- Shares sold under shelf registration statement (File No. 333-281503) effective August 12, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/0001104659-26-034579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/tm269761d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-034579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer